Posted by Michael Wonder on 28 Oct 2019
FDA approves Medicines360’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to prevent pregnancy for up to six years, the longest approved duration of use of any hormonal IUDs
28 October 2019 - Medicines360 announced that the U.S. FDA approved Medicines360’s Supplemental new drug application to extend the duration of use of Liletta (levonorgestrel-releasing intrauterine system) 52 mg for the prevention of pregnancy for up to six years.
With the FDA approval, Liletta has the longest approved duration of use for a hormonal intrauterine device (IUD or IUS) in the U.S., and is available at the lowest wholesale acquisition cost of any IUD in the U.S.
